Literature DB >> 3000797

The effect of cimetidine on the pharmacokinetics, pharmacodynamics and alpha 1-adrenoceptor responsiveness of trimazosin in man.

J Vincent, H L Elliott, P A Meredith, D M Hughes, J L Reid.   

Abstract

The effect of cimetidine treatment on the pharmacokinetics and pharmacodynamics of single doses of trimazosin was studied in 6 normotensive volunteers. Co-administration of cimetidine did not significantly affect the overall magnitude of the hypotensive effect of trimazosin. However, the time profile of the blood pressure response was significantly modified particularly with attenuation of the delayed component. Co-administration of cimetidine did not alter alpha 1-adrenoceptor antagonism by trimazosin. There was no significant change in the clearance and volume of distribution of trimazosin but there was a significant reduction in the area under the concentration-time curve for the metabolite, 1-hydroxy-trimazosin. The reduction in the AUC of 1-hydroxy-trimazosin corresponds in time with the attenuation of the delayed hypotensive response. This is consistent with the suggestion that the delayed hypotensive response is related to an active metabolite, probably 1-hydroxytrimazosin.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3000797     DOI: 10.1007/bf00544084

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  20 in total

1.  Cimetidine and bioavailability of propranolol.

Authors:  M A Donovan; A M Heagerty; L Patel; M Castleden; J E Pohl
Journal:  Lancet       Date:  1981-01-17       Impact factor: 79.321

2.  The determination of trimazosin and its metabolite CP23445 in whole blood by high performance liquid chromatography using fluorescence detection.

Authors:  M A Hughes; P A Meredith; H L Elliott
Journal:  J Pharmacol Methods       Date:  1984-08

3.  Influence of cimetidine on pharmacokinetics of propranolol.

Authors:  A M Heagerty; M A Donovan; C M Castleden; J F Pohl; L Patel; A Hedges
Journal:  Br Med J (Clin Res Ed)       Date:  1981-06-13

Review 4.  Drug interactions with cimetidine.

Authors:  A Somogyi; R Gugler
Journal:  Clin Pharmacokinet       Date:  1982 Jan-Feb       Impact factor: 6.447

5.  Does cimetidine alter the cardiac response to exercise and propranolol?

Authors:  S Warburton; L H Opie; B M Kennelly; F O Müller
Journal:  S Afr Med J       Date:  1979-06-30

6.  Cimetidine impairs nitrazepam clearance.

Authors:  H R Ochs; D J Greenblatt; R Gugler; G Müntefering; A Locniskar; D R Abernethy
Journal:  Clin Pharmacol Ther       Date:  1983-08       Impact factor: 6.875

7.  The effects of chronic oral cimetidine therapy on the cardiovascular system in man.

Authors:  S Saltissi; A Crowther; C Byrne; D J Coltart
Journal:  Br J Clin Pharmacol       Date:  1981-05       Impact factor: 4.335

8.  Cimetidine-procainamide pharmacokinetic interaction in man: evidence of competition for tubular secretion of basic drugs.

Authors:  A Somogyi; A McLean; B Heinzow
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

9.  Cimetidine increases steady state plasma levels of propranolol.

Authors:  I W Reimann; U Klotz; B Siems; J Frölich
Journal:  Br J Clin Pharmacol       Date:  1981-12       Impact factor: 4.335

10.  Cimetidine clearance and bioavailability in hepatic cirrhosis.

Authors:  J Sonne; H E Poulsen; M Døssing; N E Larsen; P B Andreasen
Journal:  Clin Pharmacol Ther       Date:  1981-02       Impact factor: 6.875

View more
  2 in total

Review 1.  Clinical pharmacokinetics of drugs used in the treatment of gastrointestinal diseases (Part II).

Authors:  K Lauritsen; L S Laursen; J Rask-Madsen
Journal:  Clin Pharmacokinet       Date:  1990-08       Impact factor: 6.447

Review 2.  Pharmacokinetic interactions of cimetidine 1987.

Authors:  A Somogyi; M Muirhead
Journal:  Clin Pharmacokinet       Date:  1987-05       Impact factor: 6.447

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.